ArticleClinical rheumatology2026
Diagnostic value of lung ultrasound vs. quantitative computed tomography in connective tissue disease-associated interstitial lung disease: a preliminary study.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Computational interpretation of modified lung ultrasound performance in CTD-ILD.Clinical rheumatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo evaluate the utility of modified lung ultrasound (LUS) and quantitative computed tomography (QCT) in assessing connective tissue disease-associated interstitial lung disease (CTD-ILD) and their correlations with high-resolution computed tomography (HRCT) of the chest.
methodsBetween October 2023 and 2024, 77 hospitalized CTD patients (57 CTD-ILD, 20 controls) who had undergone or were scheduled for chest HRCT also received LUS during their hospitalization, ensuring both assessments were completed within 1 week. The LUS and HRCT results were evaluated using modified LUS scores and Warrick scores, respectively. HRCT results were analyzed quantitatively using the "Dexin-FACT" automated analysis software.
resultsSignificant differences were observed in all LUS parameters and most QCT parameters between groups (P < 0.01), with significant correlations to ILD severity stratification (P < 0.05). Univariate analysis identified modified LUS scores, LAA
conclusionModified LUS shows potential as a practical tool for CTD-ILD detection, outperforming QCT parameters in diagnostic agreement with HRCT. These preliminary findings support LUS as an effective adjunct for CTD-ILD assessment. Key Points • Modified lung ultrasound scores outperformed traditional ultrasound metrics in distinguishing connective tissue disease-associated interstitial lung disease severity and showed the strongest predictive association with disease presence. • Significant differences in lung ultrasound and quantitative CT parameters were observed between connective tissue disease-associated interstitial lung disease and non-interstitial lung disease groups, correlating with disease progression and severity stratification. • Modified lung ultrasound demonstrated superior specificity to quantitative CT in detecting connective tissue disease-associated interstitial lung disease, highlighting its potential as a practical, non-invasive adjunct to HRCT.
Indexed as
Identifiers
41537945What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.